Plain-English translation of NCT04282083 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a large collection of medical information from patients with neuroendocrine tumors (rare cancers that start in hormone-producing cells of the digestive system). Researchers are gathering data from hospitals across Italy to better understand these tumors, how they develop, and how patients respond to treatment. Your medical records, test results, and follow-up information would be securely stored and used to improve care for current and future patients.
Neuroendocrine tumors are rare and not well understood. By collecting information from many patients in one place, doctors can spot patterns, learn what treatments work best, and ultimately provide better care for people with these cancers.
You likely qualify if…
You likely don't qualify if…
You would enroll when you visit the hospital or have surgery related to your tumor. Doctors at the participating hospital would enter your medical information (test results, imaging scans, treatment details, and follow-up appointments) into a secure online database. Follow-up visits would happen as your doctor normally schedules them based on your individual care needs — the study doesn't add extra appointments. Your information would be kept private using a patient code instead of your name.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy